Site Search
Professionals 214 results
Capabilities 58 results
Industry
Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations.
Industry
Practice Area
Privacy: Regulated Personal Information (RPI)
Winston’s Regulated Personal Information (RPI) Practice offers seamlessly integrated counseling and litigation services to companies looking for practical and solution-oriented assistance navigating the compliance, regulatory, and private class action enforcement risks presented by the emerging patchwork of complex (and often conflicting) privacy laws in the United States and beyond.
Experience 142 results
Experience
|July 17, 2025
Experience
|July 15, 2025
Atsion Commits Up to $200 Million in Strategic OFA Investment
Experience
|June 4, 2025
Winston Represents Chart Industries in Sale to Baker Hughes Company
Insights & News 1,463 results
Press Release
|August 21, 2025
|2 Min Read
Chicago—August 21, 2025—I have agreed to a settlement that resolves my breach of contract, defamation, and intentional infliction of emotional distress claims against Northwestern University and its President.
Speaking Engagement
|August 21, 2025
Partner Mike Blankenship Speaks with Crypto Law Summit
Mike Blankenship, Co-Chair, Capital Markets Practice, will be the featured speaker during Crypto Law Summit’s Taking Crypto Companies Public: IPO Strategies in the Digital Asset Era webinar.
In the Media
|August 21, 2025
|2 Min Read
Aparna Sehgal Discusses European CRE Recovery with Structured Credit Investor
Winston & Strawn partner Aparna Sehgal spoke with Structured Credit Investor to discuss the findings of the Bayes Business School’s latest European Commercial Real Estate Lending report and the legal issues and trends underpinning them. In addition to valuable data on deal volumes and covenant and pricing terms, the report on European real estate debt markets offers insight into how underlying funding structures and bank participation through the repo/loan-on-loan market are shaping the recovery of different real estate markets at a national and sector level. According to the report, U.K. property values and deal activity have rebounded faster, while European markets remain challenged by a mix of stalled development sales, rising capital costs, and stricter environmental upgrade requirements hold back volumes.
Other Results 66 results
Law Glossary
Generic drugs are typically small, chemically synthesized molecules—that is, they have relatively low molecular weights, frequently less than 1000 daltons and usually between 300 and 700 daltons. Biosimilars, on the other hand, are typically substantially larger in molecular weight than small molecule drugs. For example, a monoclonal antibody—a typical biosimilar drug—generally has a molecular weight in excess of 150,000 daltons. In contrast, aspirin—a typical small molecule drug—has a molecular weight of 180 daltons.
Law Glossary
A biologic—or biologic product—is a medicine made from or by living cells, typically through a series of complex processing steps. The Public Health Service Act defines a “biological product” as “a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or another trivalent organic arsenic compound), applicable to the prevention, treatment, or cure of a disease or condition of human beings.” (42 U.S.C. § 262(i).)
Law Glossary
What Is a Qualified Retirement Plan?
A qualified retirement plan is a retirement plan established by an employer that is designed to provide retirement income to designated employees and their beneficiaries, which meets certain IRS Code requirements in terms of both form and operation. Common plan types are 401(k) plans, pension plans, and profit-sharing plans. A qualified retirement plan may allow for both employer and employee contributions. Employers must follow procedures to ensure participants and beneficiaries are able to receive their benefits. They must also stay apprised of changes in retirement plan laws and regulations. Qualified retirement plans provide certain tax advantages to employers and tax deferral advantages to employees who are contributing. Taxes on earnings from the contributions are also deferred until the employee withdraws them from the plan.